Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewZ-DEVD-FMK Caspase-3 Inhibitor is a cell-permeable, irreversible inhibitor of caspase-3/CPP32. It inhibits tumor cell apoptosis. In vivo, it has a neuroprotective effect in rat hippocampus following seizures. It also significantly reduces post-traumatic apoptosis, and improved neurological recovery, before and after induced traumatic brain injury in rat.
M. Wt | 668.67 |
Formula | C30H41FN4O12 |
Sequence |
DEVD (Modifications: Asp-1 = Z-Asp(OMe), Glu-2 = Glu(OMe), Asp-4 = DL-Asp(OMe)-fluoromethylketone) |
Storage | Store at -20°C |
Purity | ≥95% (HPLC) |
CAS Number | 634911-78-7 |
InChI Key | GBJVAVGBSGRRKN-OXMHKTTFSA-N |
Smiles | [H]N(C(OCC1=CC=CC=C1)=O)[C@H](C(N[C@H](C(N[C@H](C(NC(C(CF)=O)CC(OC)=O)=O)C(C)C)=O)CCC(OC)=O)=O)CC(OC)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility | Soluble to 1 mg/ml in DMSO |
References are publications that support the biological activity of the product.
Brocksted et al (1998) Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. J.Biol.Chem. 273 28057 PMID: 9774422
Henshall et al (2000) Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J.Neurochem. 74 1215 PMID: 10693954
Kugawa et al (2000) Apoptosis of NG108-15 cells induced by Bupren. hydrochloride occurs via the caspase-3 pathway. Biol.Pharm.Bull. 23 930 PMID: 10963298
Yakovlev et al (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J.Neurosci. 17 7415 PMID: 9295387
If you know of a relevant reference for Z-DEVD-FMK Caspase-3 Inhibitor, please let us know.
Keywords: Z-DEVD-FMK Caspase-3 Inhibitor, Z-DEVD-FMK Caspase-3 Inhibitor supplier, cell-permeable, irreversible, caspase-3, inhibitors, inhibits, caspases, proteinases, proteases, in, vivo, apoptosis, neuroprotective, brain, injury, Caspases, 8009, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Z-DEVD-FMK Caspase-3 Inhibitor. Do you know of a great paper that uses Z-DEVD-FMK Caspase-3 Inhibitor from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Z-DEVD-FMK Caspase-3 Inhibitor and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:
In normal cells, each stage of the cell cycle is tightly regulated, however in cancer cells many genes and proteins that are involved in the regulation of the cell cycle are mutated or over expressed. This poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.